Literature DB >> 33742188

Building confidence in circulating tumour DNA assays for metastatic castration-resistant prostate cancer.

Sarah W S Ng1, Alexander W Wyatt2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33742188     DOI： 10.1038/s41585-021-00455-3

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  3 in total

1.  BRCA2, ATM, and CDK12 Defects Differentially Shape Prostate Tumor Driver Genomics and Clinical Aggression.

Authors:  Evan Warner; Cameron Herberts; Simon Fu; Steven Yip; Amanda Wong; Gang Wang; Elie Ritch; Andrew J Murtha; Gillian Vandekerkhove; Nicolette M Fonseca; Arkhjamil Angeles; Arshia Beigi; Elena Schönlau; Kevin Beja; Matti Annala; Daniel Khalaf; Kim N Chi; Alexander W Wyatt
Journal:  Clin Cancer Res       Date:  2021-01-07       Impact factor: 12.531

Review 2.  Practical considerations for optimising homologous recombination repair mutation testing in patients with metastatic prostate cancer.

Authors:  David Gonzalez; Joaquin Mateo; Albrecht Stenzinger; Federico Rojo; Michelle Shiller; Alexander W Wyatt; Frédérique Penault-Llorca; Leonard G Gomella; Ros Eeles; Anders Bjartell
Journal:  J Pathol Clin Res       Date:  2021-02-25

3.  Genomic Analysis of Circulating Tumor DNA in 3,334 Patients with Advanced Prostate Cancer Identifies Targetable BRCA Alterations and AR Resistance Mechanisms.

Authors:  Hanna Tukachinsky; Russell W Madison; Jon H Chung; Ole V Gjoerup; Eric A Severson; Lucas Dennis; Bernard J Fendler; Samantha Morley; Lei Zhong; Ryon P Graf; Jeffrey S Ross; Brian M Alexander; Wassim Abida; Simon Chowdhury; Charles J Ryan; Karim Fizazi; Tony Golsorkhi; Simon P Watkins; Andrew Simmons; Andrea Loehr; Jeffrey M Venstrom; Geoffrey R Oxnard
Journal:  Clin Cancer Res       Date:  2021-02-08       Impact factor: 13.801
  3 in total
  2 in total

1.  Recommendations for the implementation of genetic testing for metastatic prostate cancer patients in Canada.

Authors:  Shamini Selvarajah; Kasmintan A Schrader; Michael P Kolinsky; Ricardo A Rendon; Soufiane El Hallani; Neil E Fleshner; Sebastien J Hotte; Justin Lorentz; Karen Panabaker; Renée Perrier; Frédéric Pouliot; Alan Spatz; Stephen Yip; Kim N Chi
Journal:  Can Urol Assoc J       Date:  2022-10       Impact factor: 2.052

2.  Real-World Performance of a Comprehensive Genomic Profiling Test Optimized for Small Tumor Samples.

Authors:  Scott A Tomlins; Daniel H Hovelson; Jennifer M Suga; Daniel M Anderson; Han A Koh; Elizabeth C Dees; Brendan McNulty; Mark E Burkard; Michael Guarino; Jamil Khatri; Malek M Safa; Marc R Matrana; Eddy S Yang; Alex R Menter; Benjamin M Parsons; Jennifer N Slim; Michael A Thompson; Leon Hwang; William J Edenfield; Suresh Nair; Adedayo Onitilo; Robert Siegel; Alan Miller; Timothy Wassenaar; William J Irvin; William Schulz; Arvinda Padmanabhan; Vallathucherry Harish; Anneliese Gonzalez; Abdul Hai Mansoor; Andrew Kellum; Paul Harms; Stephanie Drewery; Jayson Falkner; Andrew Fischer; Jennifer Hipp; Kat Kwiatkowski; Lorena Lazo de la Vega; Khalis Mitchell; Travis Reeder; Javed Siddiqui; Hana Vakil; D Bryan Johnson; Daniel R Rhodes
Journal:  JCO Precis Oncol       Date:  2021-08-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.